These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32884216)

  • 1. Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development.
    Singh PK; Kulsum U; Rufai SB; Mudliar SR; Singh S
    J Lab Physicians; 2020 Aug; 12(2):154-160. PubMed ID: 32884216
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV).
    Kumar S; Maurya VK; Prasad AK; Bhatt MLB; Saxena SK
    Virusdisease; 2020 Mar; 31(1):13-21. PubMed ID: 32206694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
    Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational Changes of the Receptor Binding Domain of SARS-CoV-2 Spike Protein and Prediction of a B-Cell Antigenic Epitope Using Structural Data.
    Khare S; Azevedo M; Parajuli P; Gokulan K
    Front Artif Intell; 2021; 4():630955. PubMed ID: 33842877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Diversity and Hotspot Mutations in 30,983 SARS-CoV-2 Genomes: Moving Toward a Universal Vaccine for the "Confined Virus"?
    Alouane T; Laamarti M; Essabbar A; Hakmi M; Bouricha EM; Chemao-Elfihri MW; Kartti S; Boumajdi N; Bendani H; Laamarti R; Ghrifi F; Allam L; Aanniz T; Ouadghiri M; El Hafidi N; El Jaoudi R; Benrahma H; Attar JE; Mentag R; Sbabou L; Nejjari C; Amzazi S; Belyamani L; Ibrahimi A
    Pathogens; 2020 Oct; 9(10):. PubMed ID: 33050463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape.
    Wang L; Shi W; Chappell JD; Joyce MG; Zhang Y; Kanekiyo M; Becker MM; van Doremalen N; Fischer R; Wang N; Corbett KS; Choe M; Mason RD; Van Galen JG; Zhou T; Saunders KO; Tatti KM; Haynes LM; Kwong PD; Modjarrad K; Kong WP; McLellan JS; Denison MR; Munster VJ; Mascola JR; Graham BS
    J Virol; 2018 May; 92(10):. PubMed ID: 29514901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of mutational hotspots in the spike protein of SARS-CoV-2 isolates from different geographic origins.
    Lee S; Lee MK; Na H; Ahn J; Hong G; Lee Y; Park J; Kim Y; Kim YT; Kim CK; Lim HS; Lee KR
    Gene Rep; 2021 Jun; 23():101100. PubMed ID: 33778182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation profile of SARS-CoV-2 spike protein and identification of potential multiple epitopes within spike protein for vaccine development against SARS-CoV-2.
    Paul D; Pyne N; Paul S
    Virusdisease; 2021 Dec; 32(4):703-726. PubMed ID: 34754886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design.
    Wang D; Mai J; Zhou W; Yu W; Zhan Y; Wang N; Epstein ND; Yang Y
    Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32635180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spike protein-based epitopes predicted against SARS-CoV-2 through literature mining.
    Li W; Li L; Sun T; He Y; Liu G; Xiao Z; Fan Y; Zhang J
    Med Nov Technol Devices; 2020 Dec; 8():100048. PubMed ID: 33052325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein.
    Joyce MG; Sankhala RS; Chen WH; Choe M; Bai H; Hajduczki A; Yan L; Sterling SL; Peterson CE; Green EC; Smith C; de Val N; Amare M; Scott P; Laing ED; Broder CC; Rolland M; Michael NL; Modjarrad K
    bioRxiv; 2020 Mar; ():. PubMed ID: 32511298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope-based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study.
    Tahir Ul Qamar M; Saleem S; Ashfaq UA; Bari A; Anwar F; Alqahtani S
    J Transl Med; 2019 Nov; 17(1):362. PubMed ID: 31703698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolutionary and Antigenic Profiling of the Tendentious D614G Mutation of SARS-CoV-2 in Gujarat, India.
    Nimavat J; Mootapally C; Nathani NM; Dave D; Kher MN; Mahajan MS; Joshi CG; Bhatt VD
    Front Genet; 2021; 12():764927. PubMed ID: 34858480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Synonymous Mutation of SARS-CoV-2: Is This Possible to Affect Their Antigenicity and Immunogenicity?
    Kim SJ; Nguyen VG; Park YH; Park BK; Chung HC
    Vaccines (Basel); 2020 May; 8(2):. PubMed ID: 32422894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The status and analysis of common mutations found in the SARS-CoV-2 whole genome sequences from Bangladesh.
    Rahman S; Shishir MA; Hosen MI; Khan MJ; Arefin A; Khandaker AM
    Gene Rep; 2022 Jun; 27():101608. PubMed ID: 35399222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An updated analysis of variations in SARS-CoV-2 genome.
    Ugurel OM; Ata O; Turgut-Balik D
    Turk J Biol; 2020; 44(3):157-167. PubMed ID: 32595352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable number tandem repeats of a 9-base insertion in the N-terminal domain of severe acute respiratory syndrome coronavirus 2 spike gene.
    Akaishi T; Fujiwara K; Ishii T
    Front Microbiol; 2022; 13():1089399. PubMed ID: 36687631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D614G mutation alters SARS-CoV-2 spike conformational dynamics and protease cleavage susceptibility at the S1/S2 junction.
    Gobeil S; Janowska K; McDowell S; Mansouri K; Parks R; Manne K; Stalls V; Kopp M; Henderson R; Edwards RJ; Haynes BF; Acharya P
    bioRxiv; 2020 Oct; ():. PubMed ID: 33052347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and molecular characterization of mutations in nucleocapsid phosphoprotein of SARS-CoV-2.
    Azad GK
    PeerJ; 2021; 9():e10666. PubMed ID: 33505806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SAS: A Platform of Spike Antigenicity for SARS-CoV-2.
    Zhang L; Cao R; Mao T; Wang Y; Lv D; Yang L; Tang Y; Zhou M; Ling Y; Zhang G; Qiu T; Cao Z
    Front Cell Dev Biol; 2021; 9():713188. PubMed ID: 34616728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.